A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for Crohn's Disease
Drug: Ustekinumab
45 locations incl. Dothan
Sponsor: Takeda
Sex: All·Age: 18 - 70
Code: NCT06045754·Phase 4·Recruiting